Benchmark Maintains Buy on BlueLinx Hldgs, Lowers Price Target to $75
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and lowers the price target from $83 to $75.
Benchmark analyst Reuben Garner maintains BlueLinx Hldgs (NYSE:BXC) with a Buy and lowers the price target from $83 to $75.